ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Supports New Cervical Cancer Screening Guideline

January 31, 2003

NCI CTEP-Approved Trials For the Month of December

December 26, 2014

Holden, Mayo, Hopkins Win Lymphoma SPOREs; Hutchinson Wins Prostate SPORE

October 4, 2002

Center Seeks HER-2 Positive Breast Cancer Patients

August 29, 2003

Bush May Nominate Zerhouni For NIH Director

March 8, 2002

SPOREs In Breast, Prostate Cancers Win $12.7 Million.

October 6, 2000